Elizabeth

 

Mittendorf

Dr. Mittendorf, a surgical oncologist at the Beth Israel Deaconess Medical Center, is the Chief of Multidisciplinary Oncology at the Dana-Farber Cancer Institute, Co-Leader of the Breast Program for the Harvard Cancer Consortium, and a Professor of Surgery at Harvard Medical School in Boston, Massachusetts. Dr. Mittendorf received her medical degree from Case Western Reserve University School of Medicine where she also completed a residency in General Surgery. She then served on active duty in the United States military before completing a fellowship in Surgical Oncology at the University of Texas MD Anderson Cancer Center. Dr. Mittendorf also holds a PhD in Immunology from the University of Texas Graduate School of Biomedical Sciences at Houston. 

Dr. Mittendorf currently serves as President on the ASCO Society Board of Directors for the 2026–2027 term, having previously served as a Board member from 2019 to 2023 and as the Society Treasurer from 2022 to 2023. She has served as a member of various ASCO volunteer groups including the Annual Meeting Scientific Program Committee, the Best of ASCO Planning Committee, and as Chair of the Conquer Cancer Grants and Awards Selection Committee. Dr. Mittendorf serves on the advisory boards and executive committees of several national surgical and scientific organizations dedicated to advancing breast cancer care.